Claire Winiarek is Vice President, Policy for PCMA. In this role, she leads the association’s policy development activities in support of the industry’s federal and state legislative and regulatory advocacy efforts. Prior to joining PCMA, Claire served as the Director
In case you missed it, the National Institute for Public Employee Health Care Policy recently released a report, “How Public Sector Health Care Purchasers Are Addressing Rising Drug Costs.” According to the report, “Through pooled purchasing organizations, employers in the
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued 21 policy solutions supported by America’s pharmacy benefit managers (PBMs) aimed at reducing prescription drug costs for patients and health plan sponsors. PBMs administer prescription drug plans for more than 266 million Americans with
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) will hold its annual “PBM Policy Forum” tomorrow, April 19, at the Newseum in Washington, D.C. This year’s event features subject matter experts explaining key issues in the drug supply chain
Today, Thursday March 9, The Hill is hosting an important conversation titled: “Prescription for Change: Improving Competition to Lower Drug Prices,” featuring: David Schweikert (R-AZ), Member, Ways & Means Committee Tina Smith (D-MN), Member, Senate HELP Committee Lauren Aronson, Executive
A recent report from the Massachusetts Health Policy Commission used publicly available drug pricing data in an attempt to identify proxies to highlight the differences between what health plan sponsors reimburse their pharmacy benefit managers (PBM) for a prescription versus
In a new web video, Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott discusses the critical role and value of pharmacy benefit companies, the root cause of high prescription drug prices, and how solutions to boost competition, especially
Claire Winiarek is Vice President of Policy for the Pharmaceutical Care Management Association (PCMA). In this role, she leads PCMA’s policy development activities in support of the industry’s federal and state legislative and regulatory advocacy efforts. Prior to joining PCMA,
JC Scott, president and CEO of the PBMs’ national trade group, the Pharmaceutical Care Management Association, said in a statement: “We are currently reviewing the proposed rule. However, previous point-of-sale proposals in Medicare have not advanced because they would significantly increase Medicare spending.”
©2024 PCMA. All Rights Reserved.
